PYXS/ 12/18/2025 · 10:51 AM Pyxis Oncology's MICVO Shows Promise But Raises Concerns Pyxis stock plunged 45% despite positive cancer drug results. Small patient sample, safety issues, and 2026 data timeline worried investors.
